Pre-medication with pronase reduces artefacts during endoscopic ultrasonography

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 3, 2003, Pages 327-332

  Sakai, N ^a,b   Tatsuta, M ^a   Iishi, H ^a   Nakaizumi, A ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b KINKI CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIFOAMING AGENT; BICARBONATE; CREATININE; DIMETICONE; GASCON; HEMOGLOBIN; PRONASE; PRONASE MS; PROTEINASE; SCOPOLAMINE BUTYL BROMIDE; UNCLASSIFIED DRUG; UREA NITROGEN;

ADULT; AGED; ANEMIA; ARTICLE; ARTIFACT REDUCTION; CLINICAL TRIAL; CREATININE CLEARANCE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPY; ERYTHROPENIA; FEMALE; HEMATOCRIT; HUMAN; LEUKOPENIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PEPTIC ULCER BLEEDING; POSTOPERATIVE COMPLICATION; PREMEDICATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PRURITUS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STOMACH MOTILITY; STOMACH MUCUS; STOMACH WALL; UREA NITROGEN BLOOD LEVEL;

ARTIFACTS; ENDOSONOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREMEDICATION; PRONASE;

EID: 0041823867     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01582.x     Document Type: Article

References (15)

1. Takemoto T, Tada M, Yanai H, Karita M, Okita K. Significance of strip biopsy, with special reference to endoscopic 'mucosectomy'. Dig Endosc 1989; 1: 4-9.
2. Tatsuta M, Iishi H, Narahara H, Uedo N. Technique Manual of Endoscopic Mucosal Resection. Tokyo: Nankodo, 2002.
3. Tatsuta M, Iishi H, Nakaizumi A, Uehara H. Technique Manual of Endoscopic Ultrasonography. Tokyo: Nankodo, 1998.
4. Nakaizumi A, Tatsuta M, Uehara H, et al. A prospective trial of early detection of pancreatic cancer by ultrasonographic examination combined with measurement of serum elastase 1. Cancer 1992; 69: 936-40.
5. Yiengpruksawan A, Lightdale CJ, Gerdes H, Botet JF. Mucolytic-antifoam solution for reduction of artifacts during endoscopic ultrasonography: a randomized control trial. Gastrointest Endosc 1991; 37: 543-6.
6. Fujii T, Iishi H, Tatsuta M, et al. Effectiveness of premedication with pronase for improving visibility during gastroendoscopy: a randomized controlled trial. Gastrointest Endosc 1998; 47: 382-7.
7. Siegel S. Nonparametric Statistics for the Behavioral Sciences. New York: McGraw-Hill, 1956.
8. Snedecor GW, Cochran WG. Statistical Methods. Ames, IA: The Iowa State University Press. 1967.
9. Kawahara B. Clinical experience in the use of proteolytic agent (Pronase®) as a pre-procedure solution for endoscopic examination. Prog Dis Endosc 1974; 4: 62.
10. Yoshida H, Nakayama Y, Toyoshima M, Seki K. Effectiveness of premedication with pronase-MS for gastroendoscopy. Rinsho Kenkyu 1996; 73: 1939-45.
11. Okuda J, Itoh Y, Miyazaki M, et al. Premedication with pronase for gastroendoscopy: a randomized controlled trial. Rinsho Kenkyu 1996; 73: 2889-97.
12. Miki K, Murata Y, Arakawa T. Guideline for upper gastrointestinal endoscopy. In: Guideline for Gastrointestinal Endoscopy. Tokyo: Igaku-shoin, 2002: 60-9.
13. Osawa K, Takeyasu K, Shima S, et al. Effectiveness of Gascon for premedication of gastroendoscopy. Shinryo Shinyaku 1975; 12: 1101-2.
14. Yuri K, Suzuki S, Betsumiya H, et al. Usefulness of Gascon for premedication of gastroendoscopy. Shinryo Shinyaku 1975; 12: 1807-11.
15. Koga M, Arakawa K. On the application of enzymatic mucinolysis in X-ray diagnosis of the stomach. Nippon Acta Radiol 1964; 24: 1011-31.